YS
Yatin Suneja Guggenheim Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Tourmaline Bio
TRML
$645M
| $25.10 | $55 |
119%
upside
| Buy | 21 days ago |
|
2
Regeneron Pharmaceuticals
REGN
$60.1B
| $567.22 | $815 |
44%
upside
| Buy | 1 month ago |
|
3
Neurocrine Biosciences
NBIX
$13.9B
| $140.40 | $175 |
25%
upside
| Buy | 1 month ago |
|
4
argenx
ARGX
$44.9B
| $733.66 | $1,070 |
46%
upside
| Buy | 1 month ago |
|
|
ABVX
5
Abivax
ABVX
$6.47B
| $85.55 | $101 |
18%
upside
| Buy | 1 month ago |
|
6
Larimar Therapeutics
LRMR
$331M
| $3.87 | $26 |
572%
upside
| Buy | 2 months ago |
|
|
ALMS
7
Alumis Inc. Common Stock
ALMS
$475M
| $4.60 | $18 |
291%
upside
| Buy | 2 months ago |
|
8
AnaptysBio
ANAB
$590M
| $21.09 | $90 |
327%
upside
| Buy | 3 months ago |
|
9
GH Research
GHRS
$872M
| $14.05 | $29 |
106%
upside
| Buy | 3 months ago |
|
10
Phathom Pharmaceuticals
PHAT
$851M
| $12 | $12 |
0%
upside
| Buy | 4 months ago |
|
11
Dianthus Therapeutics
DNTH
$794M
| $24.66 | $84 |
241%
upside
| Buy | 5 months ago |
|
|
ZBIO
12
Zenas BioPharma, Inc. Common Stock
ZBIO
$715M
| $16.98 | $45 |
165%
upside
| Buy | 5 months ago |
|
13
Acadia Pharmaceuticals
ACAD
$4.3B
| $25.50 | $20 |
22%
downside
| Neutral | 8 months ago |
|
14
Spyre Therapeutics
SYRE
$1.03B
| $16.99 | $65 |
283%
upside
| Buy | 10 months ago |
|
15
Praxis Precision Medicines
PRAX
$970M
| $46.09 | $170 |
269%
upside
| Buy | 1 year ago |
|
16
Celldex Therapeutics
CLDX
$1.51B
| $22.78 | $90 |
295%
upside
| Buy | 1 year ago |
|
17
Axsome Therapeutics
AXSM
$6.21B
| $124.41 | $125 |
0%
upside
| Buy | 1 year ago |
|
18
Roivant Sciences
ROIV
$8.58B
| $12.57 | $16 |
27%
upside
| Buy | 1 year ago |
|
19
MoonLake Immunotherapeutics
MLTX
$3.79B
| $59.72 | $77 |
29%
upside
| Buy | 1 year ago |
|
20
Xenon Pharmaceuticals
XENE
$2.98B
| $38.64 | $49 |
27%
upside
| Buy | 2 years ago |
|
21
EyePoint Pharmaceuticals
EYPT
$819M
| $11.88 | $55 |
363%
upside
| Buy | 2 years ago |
|
22
Biogen
BIIB
$20.5B
| $139.94 | $350 |
150%
upside
| Buy | 2 years ago |
|
23
Bausch + Lomb
BLCO
$5.16B
| $14.59 | $24 |
65%
upside
| Buy | 3 years ago |
|
|
24
AnaptysBio
ANAB
$590M
| $21.09 | $14 |
34%
downside
| Hold | 5 years ago |
|
|
VRNA
25
Verona Pharma
VRNA
$9.19B
| $106.24 | $34 |
68%
downside
| Buy | 5 years ago |
|